Azithromycin Eye Drops Suppliers & Bulk Manufacturers

Available Forms: Drops

Available Strengths: 1% solution

Reference Brands: AzaSite (USA), Azithral (India), Azitro (LATAM)

Category: Opthalmology

Azithromycin Eye Drops (1%) are a macrolide antibiotic ophthalmic solution, primarily used for the treatment of bacterial conjunctivitis and other susceptible eye infections. The formulation offers broad-spectrum antibacterial coverage with a convenient dosing regimen, improving patient compliance. Azithromycin Eye Drops is available in Drops and strengths such as 1% solution. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Azithromycin Eye Drops is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Azithromycin Eye Drops can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Azithromycin ophthalmic solution is a macrolide antibiotic used for the treatment of bacterial eye infections, particularly bacterial conjunctivitis. It works by inhibiting bacterial protein synthesis, thereby preventing the growth and spread of susceptible bacteria on the ocular surface. Due to its broad-spectrum antibacterial activity, azithromycin ophthalmic solution is effective against a variety of Gram-positive, Gram-negative, and certain atypical bacteria that commonly cause eye infections.

One of the well-known formulations, azithromycin 1.0% ophthalmic solution, was approved by the United States Food and Drug Administration (FDA) in 2007 for the treatment of bacterial conjunctivitis. This formulation uses a specialized delivery system that helps maintain the medication on the ocular surface for a longer period, allowing sustained drug release and reducing the need for frequent dosing. This extended contact time improves treatment effectiveness and enhances patient compliance.

In addition to its primary indication for bacterial conjunctivitis, azithromycin ophthalmic solution has also been evaluated in clinical studies for other ocular conditions such as blepharitis and eyelid inflammation. Its convenient dosing schedule, proven safety profile, and broad antibacterial coverage make azithromycin ophthalmic solution an important treatment option in ophthalmic care.